Ladiratuzumab
Product Specifications
CAS Number
1629760-28-6
Target
Others, ADC Antibody
Related Pathways
Antibody-drug Conjugate/ADC Related, Others
Purity
0.982
Bioactivity
LadiratuzumAb (hLIV22) is a humanized monoclonal antibody targeting LIV-1/ZIP6.LadiratuzumAb is a naked antibody to SGN-LIV1A and is capable of synthesizing an antibody-activated molecule coupling (ADC), SGN-LIV1A.LadiratuzumAb can be used for the prevention and treatment of breast cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470262-500 1x 500 µL
Human Lambda Light Chain (HP6054), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details